T. Rowe Price Rides On Solid Revenues Despite Cost Woes
Zacks Investment Research | Dec 30, 2019 09:00PM ET
On Dec 30, 2019, we issued an updated research report on T. Rowe Price Group, Inc. (NASDAQ:TROW) . The company’s robust organic growth and initiatives to expand business make us optimistic about its prospects.
Though rising expenses are a major concern, the company’s efforts to gain investor confidence through steady capital deployment activities are encouraging.
The company’s shares have gained 31.9% in the past year, outperforming 12.1% growth of the industry it belongs to. Moreover, the Zacks Consensus Estimate for current-year earnings has been revised 0.4% upward over the past 30 days and 2.2% for 2020. This uptrend substantiates its Zacks Rank #2 (Buy).
T. Rowe Price is committed to bolster its business through new investment strategies and vehicles along with strengthening its distribution channels in the United States, EMEA and Asia Pacific, improving technology platform and deriving long-term cost efficiencies.
Further, organic growth is a key driver at T. Rowe Price, evident from its revenue growth. Net revenues saw a CAGR of 7.8% over the last five years (2014-2018). The company benefits from its diverse business model and its mix shift toward international growth funds is also expected to boost both revenue and investment-management margins.
Moreover, the company’s debt-free position and strong liquidity keep it well-poised to undertake strategic investments and growth opportunities in the future. Also, these tailwinds enable it to enhance its shareholder value through efficient capital deployment activities. In February 2019, the company hiked its quarterly common stock dividend by 8.6%.
However, persistently escalating expenses due to T. Rowe Price’s strategic efforts to attract investments from clients might affect its bottom-line growth. Also, overdependence on investment advisory fees (comprising about 90% of its net revenues) as a revenue source is another major lingering woe.
Other Stocks to Consider
TD Ameritrade Holding Corporation (NASDAQ:AMTD) has been witnessing upward estimate revisions for the past 60 days. Moreover, this Zacks #2 Ranked stock has gained more than 2% in the past year. You can see Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.